Showing results (1-10 of 430) with videos related to
Sort By:
Pageof 43
Hematology/Oncology Clinics of North America|April 4, 2006
Radiation modifiers: treatment overview and future investigationsC T Thomas, A Ammar, J J Farrell, et al.The Pharmacogenomics Journal|June 1, 2011
Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704J J Farrell, K Bae, J Wong, et al.Clinical Colorectal Cancer|November 26, 2002
Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinomaH Elsaleh, B IacopettaAustralasian Radiology|May 17, 2007
Differences in toxicity across gender in patients treated with chemoradiation for rectal cancerA Kaminski, D Joseph, H ElsalehBritish Journal of Cancer|September 15, 2001
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilB Iacopetta, F Grieu, D Joseph, et al.The Journal of Pathology|December 18, 2001
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancerG Gnanasampanthan, H Elsaleh, K McCaul, et al.Australasian Radiology|September 7, 2000
Small cell carcinoma of the vaginaH Elsaleh, S Bydder, B Cassidy, et al.The Australian and New Zealand Journal of Surgery|October 20, 1999
Pre-operative chemoradiotherapy in locally advanced rectal cancerH Elsaleh, D Joseph, M Levitt, et al.Australasian Radiology|September 5, 2001
Choroid plexus carcinoma in an adultS S Wyatt, R A Price, D Holthouse, et al.International Journal of Oncology|November 24, 1999
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomasH Elsaleh, P Soontrapornchai, F Grieu, et al.Pageof 43